GLP-1 Appetite Shift

How GLP-1 is reshaping food decisions and driving new nutritional norms in the industry.

A quiet revolution is underway. As millions turn to GLP-1 medications, the ripple effect on food is anything but silent. Appetite suppression is just the start. Consumers are redefining what “value” looks like, prioritizing nutrient density, protein, and functionality over quantity or indulgence.

What’s happening?

🌭 Appetite is down: Consumers on GLP-1s eat less frequently and in smaller quantities.
💹 Expectations are up: These consumers demand nutrient density, value, and functionality from every bite or sip.
💡 The result: Food choices are now more intentional, less driven by impulse.

This shift is forcing food and ingredient companies to rethink portfolios, reformulation strategies, and even how they communicate health and satiety.

Our latest report explores:

Which categories are most vulnerable, and where opportunity is emerging
The four zones of innovation shaping the future: Prevent, Portion, Replace, and Fortify
Strategic imperatives for brands navigating this new nutritional paradigm

Download our report for deeper insights into what this upheaval may mean for future food and nutrition strategy.

Book a short meeting with our food and nutrition strategists to explore how FutureBridge can help you de-risk your innovation pipeline, align with changing health priorities, and capture growth in the age of GLP-1.

GLP-1 Appetite Shift

Our Clients

Talk to us about how FutureBridge can address your unknowns, blind spots, innovation challenges and growth opportunities